Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2025-12-24 @ 4:40 PM
NCT ID:
NCT02970266
Eligibility Criteria:
Inclusion Criteria:
Patients:
* Patients of all ages
* Patients with symptoms the day of the first consultation allowing to ask the diagnosis of leber congenital amaurosis.
* Are affiliated to a social health care.
* Written informed consent must be given by patients or holders parental authority for minors.
patients and siblings:
* Signed consent for molecular study by the participant or by holders parental authority for minors.
* Are affiliated to a social health care.
Exclusion Criteria:
* Patients whose exploration has laid differential diagnoses.
* Patients refusing the visits provided for in Protocol.
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT02970266
Study Brief:
Protocol Section:
NCT02970266